Is narcolepsy a classical autoimmune disease?

Shoenfeld, 2011, ‘Asia’ – autoimmune/inflammatory syndrome induced by adjuvants, J Autoimmun, 36, 4, 10.1016/j.jaut.2010.07.003 Perricone, 2013, Autoimmune/inflammatory syndrome induced by adjuvants (Asia) 2013: unveiling the pathogenic, clinical and diagnostic aspects, J Autoimmun, 47, 1, 10.1016/j.jaut.2013.10.004 Cohen, 1996, Vaccine-induced autoimmunity, J Autoimmun, 9, 699, 10.1006/jaut.1996.0091 Ahmed, 2014, Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants, J Autoimmun, 50, 1, 10.1016/j.jaut.2014.01.033 Longstreth, 2007, The epidemiology of narcolepsy, Sleep, 30, 13, 10.1093/sleep/30.1.13 Wilner, 1988, Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. A study at the serological and genomic level, Hum Immunol, 21, 15, 10.1016/0198-8859(88)90077-8 Al Rajeh, 1993, A community survey of neurological disorders in Saudi Arabia: the Thugbah study, Neuroepidemiology, 12, 164, 10.1159/000110316 Akintomide, 2011, Narcolepsy: a review, Neuropsychiatr Dis Treat, 7, 507, 10.2147/NDT.S23624 Fontana, 2010, Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?, Brain, 133, 1300, 10.1093/brain/awq086 Sakurai, 2010, The orexin system: roles in sleep/wake regulation, Ann N Y Acad Sci, 1200, 149, 10.1111/j.1749-6632.2010.05513.x 2014 Blouin, 2005, Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy, Neurology, 65, 1189, 10.1212/01.wnl.0000175219.01544.c8 Crocker, 2005, Concomitant loss of dynorphin, narp, and orexin in narcolepsy, Neurology, 65, 1184, 10.1212/01.WNL.0000168173.71940.ab Thannickal, 2009, Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy, Sleep, 32, 993, 10.1093/sleep/32.8.993 Rolls, 2010, Sleep and metabolism: role of hypothalamic neuronal circuitry, Best Pract Res Clin Endocrinol Metab, 24, 817, 10.1016/j.beem.2010.08.002 Rose, 1993, Defining criteria for autoimmune diseases (Witebsky's postulates revisited), Immunol Today, 14, 426, 10.1016/0167-5699(93)90244-F Anaya, 2010, The autoimmune tautology, Arthritis Res Ther, 12, 147, 10.1186/ar3175 Tanaka, 2014, Increased plasma IL-6, IL-8, TNF-alpha, and G-CSF in Japanese narcolepsy, Hum Immunol, 75, 940, 10.1016/j.humimm.2014.06.023 Dauvilliers, 2014, Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case–control study, Brain Behav Immun, 37, 260, 10.1016/j.bbi.2013.12.019 Hong, 2000, Clinical and polysomnographic features in DQB1*0602 positive and negative narcolepsy patients: results from the modafinil clinical trial, Sleep Med, 1, 33, 10.1016/S1389-9457(99)00007-6 Peyron, 2000, A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains, Nat Med, 6, 991, 10.1038/79690 Mignot, 2014, History of narcolepsy at Stanford university, Immunol Res, 58, 315, 10.1007/s12026-014-8513-4 Partinen, 2014, Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination, Lancet Neurol, 13, 600, 10.1016/S1474-4422(14)70075-4 Katzav, 2013, Passive transfer of narcolepsy: anti-Trib2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice, J Autoimmun, 45, 24, 10.1016/j.jaut.2013.06.010 Smith, 2004, A functional autoantibody in narcolepsy, Lancet, 364, 2122, 10.1016/S0140-6736(04)17553-3 Cvetkovic-Lopes, 2010, Elevated tribbles homolog 2-specific antibody levels in narcolepsy patients, J Clin Invest, 120, 713, 10.1172/JCI41366 Lim, 2010, The trouble with tribbles: do antibodies against Trib2 cause narcolepsy, Sleep, 33, 857, 10.1093/sleep/33.7.857 Kawashima, 2010, Anti-tribbles homolog 2 (Trib2) autoantibodies in narcolepsy are associated with recent onset of cataplexy, Sleep, 33, 869, 10.1093/sleep/33.7.869 Kiss-Toth, 2004, Human tribbles, a protein family controlling mitogen-activated protein kinase cascades, J Biol Chem, 279, 42703, 10.1074/jbc.M407732200 Takasato, 2008, Trb2, a mouse homolog of tribbles, is dispensable for kidney and mouse development, Biochem Biophys Res Commun, 373, 648, 10.1016/j.bbrc.2008.06.088 Czibere, 2011, Profiling trait anxiety: transcriptome analysis reveals cathepsin B (Ctsb) as a novel candidate gene for emotionality in mice, PLoS ONE, 6, e23604, 10.1371/journal.pone.0023604 Bergman, 2014, Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns, Proc Natl Acad Sci U S A, 111, E3735, 10.1073/pnas.1412189111 Guan, 2002, Reciprocal synaptic relationships between orexin- and melanin-concentrating hormone-containing neurons in the rat lateral hypothalamus: a novel circuit implicated in feeding regulation, Int J Obes Relat Metab Disord, 26, 1523, 10.1038/sj.ijo.0802155 Rao, 2008, Regulation of synaptic efficacy in hypocretin/orexin-containing neurons by melanin concentrating hormone in the lateral hypothalamus, J Neurosci, 28, 9101, 10.1523/JNEUROSCI.1766-08.2008 De la Herran-Arita, 2013, Cd4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy, Sci Transl Med, 5, 216ra176, 10.1126/scitranslmed.3007762 De la Herran-Arita, 2014, Retraction of the research article: Cd4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy, Sci Transl Med, 6, 247rt1, 10.1126/scitranslmed.3009995 Underwood, 2014, Immunology key narcolepsy-influenza vaccine findings retracted, Science, 345, 498, 10.1126/science.345.6196.498 van der Heide, 2014, HLA dosage effect in narcolepsy with cataplexy, Immunogenetics Mignot, 2001, Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups, Am J Hum Genet, 68, 686, 10.1086/318799 Kornum, 2011, Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain, Curr Opin Neurobiol, 21, 897, 10.1016/j.conb.2011.09.003 Hallmayer, 2009, Narcolepsy is strongly associated with the T-cell receptor alpha locus, Nat Genet, 41, 708, 10.1038/ng.372 Faraco, 2013, Immunochip study implicates antigen presentation to T cells in narcolepsy, PLoS Genet, 9, e1003270, 10.1371/journal.pgen.1003270 Winkelmann, 2012, Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy, Hum Mol Genet, 21, 2205, 10.1093/hmg/dds035 Han, 2012, TCRA, P2RY11, and CPT1B/CHKB associations in Chinese narcolepsy, Sleep Med, 13, 269, 10.1016/j.sleep.2011.06.020 Anaya, 2014, The diagnosis and clinical significance of polyautoimmunity, Autoimmun Rev, 13, 423, 10.1016/j.autrev.2014.01.049 Cardenas-Roldan, 2013, How do autoimmune diseases cluster in families? A systematic review and meta-analysis, BMC Med, 11, 73, 10.1186/1741-7015-11-73 Ohayon, 2006, Occurrence of sleep disorders in the families of narcoleptic patients, Neurology, 67, 703, 10.1212/01.wnl.0000229930.68094.48 Mignot, 1998, Genetic and familial aspects of narcolepsy, Neurology, 50, S16, 10.1212/WNL.50.2_Suppl_1.S16 Silber, 2002, The epidemiology of narcolepsy in Olmsted county, Minnesota: a population-based study, Sleep, 25, 197, 10.1093/sleep/25.2.197 Nohynek, 2012, As03 adjuvanted aH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland, PLoS ONE, 7, e33536, 10.1371/journal.pone.0033536 Ohayon, 2005, How age influences the expression of narcolepsy, J Psychosom Res, 59, 399, 10.1016/j.jpsychores.2005.06.065 Picchioni, 2007, A case–control study of the environmental risk factors for narcolepsy, Neuroepidemiology, 29, 185, 10.1159/000111581 Ton, 2010, Environmental toxins and risk of narcolepsy among people with HLA DQB1*0602, Environ Res, 110, 565, 10.1016/j.envres.2010.05.002 Ton, 2009, Active and passive smoking and risk of narcolepsy in people with HLA DQB1*0602: a population-based case–control study, Neuroepidemiology, 32, 114, 10.1159/000177037 Rose, 2001, Infection, mimics, and autoimmune disease, J Clin Invest, 107, 943, 10.1172/JCI12673 Kivity, 2009, Infections and autoimmunity – friends or foes, Trends Immunol, 30, 409, 10.1016/j.it.2009.05.005 Sfriso, 2010, Infections and autoimmunity: the multifaceted relationship, J Leukoc Biol, 87, 385, 10.1189/jlb.0709517 Wucherpfennig, 2001, Mechanisms for the induction of autoimmunity by infectious agents, J Clin Invest, 108, 1097, 10.1172/JCI200114235 Samarkos, 2005, The role of infections in the pathogenesis of autoimmune diseases, Curr Drug Targets Inflamm Allergy, 4, 99, 10.2174/1568010053622821 Aran, 2009, Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset, Sleep, 32, 979, 10.1093/sleep/32.8.979 Dauvilliers, 2010, Post-H1N1 narcolepsy-cataplexy, Sleep, 33, 1428, 10.1093/sleep/33.11.1428 Viorritto, 2012, Narcolepsy in the pediatric population, Curr Neurol Neurosci Rep, 12, 175, 10.1007/s11910-011-0246-3 Cunningham, 2012, Streptococcus and rheumatic fever, Curr Opin Rheumatol, 24, 408, 10.1097/BOR.0b013e32835461d3 Commons, 2014, Streptococcal superantigens: categorization and clinical associations, Trends Mol Med, 20, 48, 10.1016/j.molmed.2013.10.004 Koepsell, 2010, Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case–control study in genetically predisposed people, J Sleep Res, 19, 80, 10.1111/j.1365-2869.2009.00756.x Snider, 2003, Post-streptococcal autoimmune disorders of the central nervous system, Curr Opin Neurol, 16, 359, 10.1097/00019052-200306000-00017 Dale, 2002, Post-streptococcal autoimmune psychiatric and movement disorders in children, Br J Psychiatry, 181, 188, 10.1192/bjp.181.3.188 Dale, 2005, Post-streptococcal autoimmune disorders of the central nervous system, Dev Med Child Neurol, 47, 785, 10.1017/S0012162205001647 Dale, 2006, Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease, J Neuroimmunol, 172, 187, 10.1016/j.jneuroim.2005.10.014 Kirvan, 2003, Mimicry and autoantibody-mediated neuronal cell signaling in sydenham chorea, Nat Med, 9, 914, 10.1038/nm892 Cox, 2013, Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease, J Immunol, 191, 5524, 10.4049/jimmunol.1102592 Han, 2013, Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic, Ann Neurol, 73, 560, 10.1002/ana.23799 Han, 2011, Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China, Ann Neurol, 70, 410, 10.1002/ana.22587 O’Flanagan, 2011 Kall, 2013, The pandemrix – narcolepsy tragedy: how it started and what we know today, Acta Paediatr, 102, 2, 10.1111/apa.12012 Zhang, 2013, Increased incidence of narcolepsy following the 2009 H1N1 pandemic, Somnologie, 17, 90, 10.1007/s11818-013-0619-8 THL, 2011 Melen, 2013, No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after pandemrix vaccination campaign in Finland, PLOS ONE, 8, e68402, 10.1371/journal.pone.0068402 Wijnans, 2013, The incidence of narcolepsy in europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns, Vaccine, 31, 1246, 10.1016/j.vaccine.2012.12.015 Miller, 2013, Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis, BMJ, 346, f794, 10.1136/bmj.f794 Barker, 2014, Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action, Lancet Infect Dis, 14, 227, 10.1016/S1473-3099(13)70238-X Eurosurveillance Editorial Team, 2011, Swedish medical products agency publishes report from a case inventory study on pandemrix vaccination and development of narcolepsy with cataplexy, Euro Surveill, 16 Bardage, 2011, Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden, BMJ, 343, d5956, 10.1136/bmj.d5956 DoH, 2012 Heier, 2013, Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A, Sleep Med, 14, 867, 10.1016/j.sleep.2013.03.020 Dauvilliers, 2013, Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France, Brain, 136, 2486, 10.1093/brain/awt187 Mendes, 2012, Narcolepsy after a/H1N1 vaccination, Clinics (Sao Paulo), 67, 77, 10.6061/clinics/2012(01)12 Vrethem, 2012, A patient with both narcolepsy and multiple sclerosis in association with pandemrix vaccination, J Neurol Sci, 321, 89, 10.1016/j.jns.2012.07.025 Pulendran, 2011, Immunological mechanisms of vaccination, Nat Immunol, 12, 509, 10.1038/ni.2039 Jefferson, 2012, Vaccines for preventing influenza in healthy children, Cochrane Database Syst Rev, 8, CD004879 Jefferson, 2014, Vaccines for preventing influenza in healthy adults, Cochrane Database Syst Rev, 3, CD001269 Crucitti, 2011, Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy: a six-month update, Scand J Infect Dis, 43, 993, 10.3109/00365548.2011.608714 Waldenlind, 2013, Is the risk of narcolepsy also increased with non-adjuvanted flu vaccines?, BMJ, 346, f2769, 10.1136/bmj.f2769 Harris, 2014, Did narcolepsy occur following administration of AS03-adjuvanted A(H1N1) pandemic vaccine in Ontario, Canada? A review of post-marketing safety surveillance data, Euro Surveill, 19 Montplaisir, 2014, Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec, PLOS ONE, 9, e108489, 10.1371/journal.pone.0108489 Miller, 2013 Choe, 2012, No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study, Vaccine, 30, 7439, 10.1016/j.vaccine.2012.10.030 Tsai, 2011, Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy, Scand J Infect Dis, 43, 702, 10.3109/00365548.2011.580777 Calabro, 2011, Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes, Vaccine, 29, 1812, 10.1016/j.vaccine.2010.12.090 O’Hagan, 2012, The mechanism of action of mf59 – an innately attractive adjuvant formulation, Vaccine, 30, 4341, 10.1016/j.vaccine.2011.09.061 Walker, 2012, H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study, Clin Infect Dis, 54, 661, 10.1093/cid/cir905 Morel, 2011, Adjuvant system AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity, Vaccine, 29, 2461, 10.1016/j.vaccine.2011.01.011 Tsai, 2013, Is the adjuvant solely to blame?, BMJ, 346, f2375, 10.1136/bmj.f2375 Masoudi, 2014, The adjuvant component alpha-tocopherol triggers via modulation of NRF2 the expression and turnover of hypocretin in vitro and its implication to the development of narcolepsy, Vaccine, 32, 2980, 10.1016/j.vaccine.2014.03.085